Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
91-105 of 357
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Expanding Cancer Detection: How MCED Testing Complements Standard Screening
Project Oncology®Expanding Cancer Detection: How MCED Testing Complements Standard Screening
Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
Project Oncology®Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
- advertisement
Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
Project Oncology®Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
Project Oncology®6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Project Oncology®Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
- advertisement
Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Project Oncology®Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Immunotherapy Advances in Squamous Cell Anal Carcinoma: A New Standard of Care
Project Oncology®Immunotherapy Advances in Squamous Cell Anal Carcinoma: A New Standard of Care
Improving CAR T Referrals for Large B-Cell Lymphoma: A Path to Better Collaboration
Project Oncology®Improving CAR T Referrals for Large B-Cell Lymphoma: A Path to Better Collaboration
